138 related articles for article (PubMed ID: 36590995)
41. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
42. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
43. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
Ogouyèmi-Hounto A; Ndam NT; Fadégnon G; Azagnandji C; Bello M; Moussiliou A; Chippaux JP; Kinde Gazard D; Massougbodji A
Malar J; 2013 Nov; 12():413. PubMed ID: 24225351
[TBL] [Abstract][Full Text] [Related]
44. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
[TBL] [Abstract][Full Text] [Related]
45. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
47. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
48. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV; Beshir K; Sutherland CJ
Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
[TBL] [Abstract][Full Text] [Related]
49. Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.
Basuki S; Fitriah ; Riyanto S; Budiono ; Dachlan YP; Uemura H
Malar J; 2014 Apr; 13():135. PubMed ID: 25187019
[TBL] [Abstract][Full Text] [Related]
50. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
51. High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
Afutu LL; Boampong JN; Quashie NB
J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33404643
[TBL] [Abstract][Full Text] [Related]
52. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria.
Oboh MA; Singh US; Antony HA; Ndiaye D; Badiane AS; Ali NA; Bharti PK; Das A
Infect Genet Evol; 2018 Dec; 66():222-228. PubMed ID: 30316883
[TBL] [Abstract][Full Text] [Related]
53. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
[TBL] [Abstract][Full Text] [Related]
54. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Alifrangis M; Lusingu JP; Mmbando B; Dalgaard MB; Vestergaard LS; Ishengoma D; Khalil IF; Theander TG; Lemnge MM; Bygbjerg IC
Am J Trop Med Hyg; 2009 Apr; 80(4):523-7. PubMed ID: 19346369
[TBL] [Abstract][Full Text] [Related]
55. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
Amenga-Etego LN; Asoala V; Agongo G; Jacob C; Goncalves S; Awandare GA; Rockett KA; Kwiatkowski D
Malar J; 2021 Mar; 20(1):152. PubMed ID: 33731134
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
[TBL] [Abstract][Full Text] [Related]
57. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
Jiang T; Cheng W; Yao Y; Tan H; Wu K; Li J
Malar J; 2020 Nov; 19(1):434. PubMed ID: 33238987
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
59. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Juma DW; Muiruri P; Yuhas K; John-Stewart G; Ottichilo R; Waitumbi J; Singa B; Polyak C; Kamau E
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007223. PubMed ID: 30897090
[TBL] [Abstract][Full Text] [Related]
60. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
